Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (71-80 of 320) with videos related to

Pageof 32
Sort By:
Journal of Translational Medicine|December 5, 2021
From biobank and data silos into a data commons: convergence to support translational medicineRebecca Asiimwe, Stephanie Lam, Samuel Leung, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 17, 2019
Use of Immunohistochemical Markers (HNF-1β, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma From Its Morphologic Mimics Including Arias-Stella ReactionJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Cancer|April 30, 2008
Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomyHenry T Lynch, Pardeep Kaurah, Debrah Wirtzfeld, et al.
BMC Cancer|July 26, 2007
Use of immunohistochemical markers can refine prognosis in triple negative breast cancerMarc Tischkowitz, Jean-Sébastien Brunet, Louis R Bégin, et al.
The Journal of Pathology|August 2, 2021
FOXL2 in adult-type granulosa cell tumour of the ovary: oncogene or tumour suppressor gene?Jessica A Pilsworth, Anne-Laure Todeschini, Samantha J Neilson, et al.
Histopathology|April 17, 2018
DICER1 hot-spot mutations in ovarian gynandroblastomaYemin Wang, Anthony N Karnezis, Jamie Magrill, et al.
The Journal of Pathology|August 3, 2024
The unique metabolome of clear cell ovarian carcinomaJennifer X Ji, Lien N Hoang, Dawn R Cochrane, et al.
BMC Cancer|February 7, 2015
Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomasHector H Li-Chang, Katayoon Kasaian, Ying Ng, et al.
The American Journal of Surgical Pathology|March 8, 2011
FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovaryOsama M Al-Agha, Hassan F Huwait, Christine Chow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2010
Calculator for ovarian carcinoma subtype predictionSteve E Kalloger, Martin Köbel, Samuel Leung, et al.
Pageof 32

Showing results (71-80 of 320) with videos related to

Sort By:
Pageof 32
Journal of Translational Medicine|December 5, 2021
From biobank and data silos into a data commons: convergence to support translational medicineRebecca Asiimwe, Stephanie Lam, Samuel Leung, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 17, 2019
Use of Immunohistochemical Markers (HNF-1β, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma From Its Morphologic Mimics Including Arias-Stella ReactionJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Cancer|April 30, 2008
Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomyHenry T Lynch, Pardeep Kaurah, Debrah Wirtzfeld, et al.
BMC Cancer|July 26, 2007
Use of immunohistochemical markers can refine prognosis in triple negative breast cancerMarc Tischkowitz, Jean-Sébastien Brunet, Louis R Bégin, et al.
The Journal of Pathology|August 2, 2021
FOXL2 in adult-type granulosa cell tumour of the ovary: oncogene or tumour suppressor gene?Jessica A Pilsworth, Anne-Laure Todeschini, Samantha J Neilson, et al.
Histopathology|April 17, 2018
DICER1 hot-spot mutations in ovarian gynandroblastomaYemin Wang, Anthony N Karnezis, Jamie Magrill, et al.
The Journal of Pathology|August 3, 2024
The unique metabolome of clear cell ovarian carcinomaJennifer X Ji, Lien N Hoang, Dawn R Cochrane, et al.
BMC Cancer|February 7, 2015
Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomasHector H Li-Chang, Katayoon Kasaian, Ying Ng, et al.
The American Journal of Surgical Pathology|March 8, 2011
FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovaryOsama M Al-Agha, Hassan F Huwait, Christine Chow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2010
Calculator for ovarian carcinoma subtype predictionSteve E Kalloger, Martin Köbel, Samuel Leung, et al.
Pageof 32